These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6998899)

  • 1. Pharmacokinetics of instilled drugs in the human eye.
    Nagataki S; Mishima S
    Int Ophthalmol Clin; 1980; 20(3):33-49. PubMed ID: 6998899
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in pupil size and intraocular pressure after topical application of 0.5% tropicamide to the eyes of dogs sedated with butorphanol.
    Jugant S; Grillot AE; Lyarzhri F; Régnier A; Douet JY
    Am J Vet Res; 2019 Jan; 80(1):95-101. PubMed ID: 30605033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures and fluids involved in the penetration of topically applied drugs.
    Maurice DM
    Int Ophthalmol Clin; 1980; 20(3):7-20. PubMed ID: 6998902
    [No Abstract]   [Full Text] [Related]  

  • 4. Lacrimal and instilled fluid dynamics in rabbit eyes.
    Chrai SS; Patton TF; Mehta A; Robinson JR
    J Pharm Sci; 1973 Jul; 62(7):1112-21. PubMed ID: 4576801
    [No Abstract]   [Full Text] [Related]  

  • 5. Mydriatics release from solid and semi-solid ophthalmic formulations using different in vitro methods.
    Pescina S; Macaluso C; Gioia GA; Padula C; Santi P; Nicoli S
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1472-1479. PubMed ID: 28426341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pathological conditions on drug penetration into the anterior segment.
    Foulks GN
    Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
    [No Abstract]   [Full Text] [Related]  

  • 7. Tropicamide 1% mydriatic effect: comparison between spray in closed eyes and eye drops in open eyes.
    Portes AJ; Barbosa AC; de Mello GL; Lopes MA; Cavalcanti RS
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):632-5. PubMed ID: 22775152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counteracting the effects of mydriatics. Does it benefit the patient?
    Nelson ME; Orton HP
    Arch Ophthalmol; 1987 Apr; 105(4):486-9. PubMed ID: 3566601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing problems in the use of topical ophthalmic drops.
    Loewenstein A; Geyer O; Blanc A; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):378-9. PubMed ID: 1505772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topically applied pilocarpine. Human pupillary response as a function of drop size.
    File RR; Patton TF
    Arch Ophthalmol; 1980 Jan; 98(1):112-5. PubMed ID: 7352857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of methylcellulose and carboxymethylcellulose on the biological availability of eye drops containing pilocarpine hydrochloride].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():67-71. PubMed ID: 7052782
    [No Abstract]   [Full Text] [Related]  

  • 12. [The action of stabilised pilocarpine drops on the human eye (author's transl)].
    Stodtmeister R; Brenner J; Baur MP
    Klin Monbl Augenheilkd; 1977 May; 170(5):750-3. PubMed ID: 894973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the penetration of topically applied drugs.
    Maurice DM
    Int Ophthalmol Clin; 1980; 20(3):21-32. PubMed ID: 6998898
    [No Abstract]   [Full Text] [Related]  

  • 14. Pupillary response to four concentrations of pilocarpine in normal subjects: application to testing for Adie tonic pupil.
    Leavitt JA; Wayman LL; Hodge DO; Brubaker RF
    Am J Ophthalmol; 2002 Mar; 133(3):333-6. PubMed ID: 11860969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dipivefrin and pilocarpine on pupil diameter, automated perimetry and LogMAR acuity.
    Edgar DF; Crabb DP; Rudnicka AR; Lawrenson JG; Guttridge NM; O'Brien CJ
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):117-24. PubMed ID: 9987628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Doughty MJ; Lyle WM
    Optom Vis Sci; 1992 May; 69(5):358-68. PubMed ID: 1350669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical and clinical evaluation of soluble pilocarpine eye films].
    Maĭchuk IuF; Erichev VP
    Vestn Oftalmol; 1981; (2):48-50. PubMed ID: 7015673
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume.
    Patton TF
    J Pharm Sci; 1977 Jul; 66(7):1058-9. PubMed ID: 886449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of tropicamide mydriasis with single instillations of pilocarpine can induce substantial pseudo-myopia in young adults.
    Gilmartin B; Amer AC; Ingleby S
    Ophthalmic Physiol Opt; 1995 Sep; 15(5):475-9. PubMed ID: 8524578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.